MSRPS
CPRX

Maryland State Retirement & Pension System’s Catalyst Pharmaceutical CPRX Stock Holding History

Maryland State Retirement & Pension System’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526K Sell
16,748
-123
-0.7% -$3.63K 0.01% 920
2026
Q1 		$418K Hold
16,871
– – 0.01% 937
2025
Q4 		$394K Buy
16,871
+332
+2% +$7.4K 0.01% 974
2025
Q3 		$326K Sell
16,539
-17,157
-51% -$353K 0.01% 1065
2025
Q2 		$731K Buy
33,696
+990
+3% +$23.4K 0.02% 739
2025
Q1 		$793K Sell
32,706
-4,969
-13% -$112K 0.02% 661
2024
Q4 		$786K Hold
37,675
– – 0.02% 782
2024
Q3 		$749K Sell
37,675
-1,448
-4% -$26.8K 0.02% 824
2024
Q2 		$606K Sell
39,123
-1,139
-3% -$17.7K 0.01% 1008
2024
Q1 		$635K Buy
40,262
+3,840
+11% +$57.9K 0.01% 957
2023
Q4 		$612K Sell
36,422
-480
-1% -$6.56K 0.01% 990
2023
Q3 		$431K Sell
36,902
-1,084
-3% -$14.5K 0.01% 1142
2023
Q2 		$511K Sell
37,986
-571
-1% -$8.22K 0.01% 1078
2023
Q1 		$639K Sell
38,557
-551
-1% -$9.09K 0.01% 865
2022
Q4 		$727K Buy
39,108
+425
+1% +$6.54K 0.02% 736
2022
Q3 		$496K Buy
+38,683
New +$458K 0.04% 330

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maryland State Retirement & Pension System's CPRX Position: Q2 2026 in Review

Maryland State Retirement & Pension System reduced its Catalyst Pharmaceutical (CPRX) stake by 0.73% in Q2 2026, selling an estimated $3.63K and leaving 16,748 shares worth $526K. The position accounts for 0.01% of the portfolio, ranked #920.

Maryland State Retirement & Pension System first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. The position peaked at $793K in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Maryland State Retirement & Pension System held 16,748 shares of Catalyst Pharmaceutical worth $526K as of Q2 2026.
  • Maryland State Retirement & Pension System sold 123 Catalyst Pharmaceutical shares in Q2 2026, an estimated $3.63K.
  • Catalyst Pharmaceutical made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #920 holding.
  • Maryland State Retirement & Pension System first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • Maryland State Retirement & Pension System's Catalyst Pharmaceutical position peaked at $793K in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.